MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/jocs.16942

Медицинская библиотека · Journal of cardiac surgery · 2022

Impact of preoperative Impella support on destination left ventricular assist device outcomes.

George Timothy J, Schaffer Justin M, Harrington Katherine B, Meidan Talia G, Michael DiMaio John, Kabra Nitin, Rawitscher David A, Afzal Aasim

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Although left ventricular assist device (LVAD) implantation is associated with improved heart failure survival, the impact of pre-implantation Impella support on outcomes is unknown. We undertook this study to evaluate the impact of preoperative Impella support on LVAD outcomes.

METHODS

We conducted a retrospective review of all Heartmate 3 LVAD implants. Primary stratification was by the need for preoperative Impella support with the 5.0/5.5 device. Longitudinal survival was assessed by the Kaplan-Meier method. Multivariable Cox proportional hazards regression models were developed to evaluate mortality. Secondary outcomes included changes in laboratory values during Impella support.

RESULTS

From 2017 to 2021, 87 patients underwent LVAD implantation. Sixteen were supported with a single inotrope, 36 with dual inotropes, 27 with Impella, and 3 with extracorporeal membrane oxygenation (ECMO). When stratified by the need for Impella, there was no difference in survival at 30-days (98.3 [88.2-99.8]% vs. 96.3 [76.5-99.5]%, p = .59), 1-year (91.0 [79.8-96.2] vs. 74.9 [51.7-88.2], p = .10), or at 2 years (87.9 [74.3-94.5] vs. 74.9 [51.7-88.2], p = .15). On multivariable modeling, the need for preoperative Impella was not associated with an increased hazard of 1-year (1.24 [0.23-6.73], p = .81) or 2-year mortality (1.05 [0.21-5.19], p = .95). After 7 (5-10) days of Impella support, recipient creatinine (p < .01), creatinine clearance (p = .02), and total bilirubin (p = .053) improved and lactic acidosis resolved (p < .01).

CONCLUSIONS

Preoperative Impella support is not associated with increased short or long-term mortality but is associated with improved renal and hepatic function as well as total body perfusion before LVAD implantation.

Для цитирования: George Timothy J, Schaffer Justin M, Harrington Katherine B, Meidan Talia G, Michael DiMaio John, Kabra Nitin, Rawitscher David A, Afzal Aasim. Impact of preoperative Impella support on destination left ventricular assist device outcomes.. Journal of cardiac surgery. 2022. DOI: 10.1111/jocs.16942.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.